Lip Cancer Stage III–IV (Operable): Treatment After Surgery with Positive Margins or Extracapsular Spread

Advanced lip cancer at stage III or IV that is surgically resectable may still carry high-risk pathological features after the operation — specifically positive surgical margins and/or extracapsular spread of nodal metastasis — which call for a more intensive post-operative approach.

Clinical scenario

Lip cancer, stage III or IV, operable
Positive surgical margins and/or extracapsular spread of nodal metastasis
Patient fit for chemotherapy, age under 71 years

When these high-risk features are present in a fit patient under 71, post-operative management goes beyond standard radiotherapy alone. The evidence base supports an intensified adjuvant strategy in this population.

Treatment approach — partial overview

The protocol involves surgical resection with neck dissection and reconstruction, followed by adjuvant radiochemotherapy — combining external beam radiotherapy with concurrent platinum-based chemotherapy. Full sequencing, dosing, scheduling, and chemotherapy selection details are in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1017/S0022215116000499

For advanced disease, stages III and IV (T3, T4 N0 and T1–4 N1), traditional management includes surgical resection, neck dissection, reconstruction and post-operative RT.

In fit patients under the age of 71, adjuvant radiochemotherapy up to 66 Gy with concurrent platinum-based chemotherapy should be considered for those with positive surgical margins and/or ECS.

While the most recognised concurrent chemotherapy regimen is cisplatin 100 mg/m2 three weekly, varying doses and schedules are acceptable practice, as is substitution by carboplatin.

View source ↗